Hakutulokset - Oleg Schmidt‐Kittler

  • Näytetään 1 - 14 yhteensä 14 tuloksesta
Tarkenna hakua
  1. 1
    Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

    Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells Tekijä Christoph A. Klein, Oleg Schmidt‐Kittler, Julian Schardt, Klaus Pantel, Michael R. Speicher, Gert Riethmüller

    Julkaistu 1999
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples

    SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples Tekijä Nikolas H. Stoecklein, Andreas Erbersdobler, Oleg Schmidt‐Kittler, Joachim Diebold, Julian Schardt, Jakob R. Izbicki, Christoph A. Klein

    Julkaistu 2002
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Immunomagnetic Enrichment, Genomic Characterization, and Prognostic Impact of Circulating Melanoma Cells

    Immunomagnetic Enrichment, Genomic Characterization, and Prognostic Impact of Circulating Melanoma Cells Tekijä Anja Ulmer, Oleg Schmidt-Kittler, Jörg Fischer, Ulf Ellwanger, G. Rassner, Gert Riethmüller, Gerhard Fierlbeck, Christoph A. Klein

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations

    2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations Tekijä Genglin Jin, Zachary J. Reitman, Ivan Spasojević, Ines Batinić‐Haberle, Jian Yang, Oleg Schmidt‐Kittler, Darell D. Bigner, Hai Yan

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

    Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer Tekijä Julian Schardt, Manfred Meyer, Claudia Hartmann, Falk Schubert, Oleg Schmidt‐Kittler, Christine Fuhrmann, Bernhard Polzer, Marco Petronio, Roland Eils, Christoph A. Klein

    Julkaistu 2005
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane

    A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane Tekijä Diana Mandelker, Sandra B. Gabelli, Oleg Schmidt‐Kittler, Jiuxiang Zhu, Ian Cheong, Chuan‐Hsiang Huang, Kenneth W. Kinzler, Bert Vogelstein, L. Mario Amzel

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Mutant PIK3CA promotes cell growth and invasion of human cancer cells

    Mutant PIK3CA promotes cell growth and invasion of human cancer cells Tekijä Yardena Samuels, Luis A. Díaz, Oleg Schmidt‐Kittler, Jordan M. Cummins, Laura J. DeLong, Ian Cheong, Carlo Rago, David L. Huso, Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Victor E. Velculescu

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Structural basis of nSH2 regulation and lipid binding in PI3Kα

    Structural basis of nSH2 regulation and lipid binding in PI3Kα Tekijä Michelle S. Miller, Oleg Schmidt‐Kittler, David M. Bolduc, Evan T. Brower, Daniele Chaves‐Moreira, Marc Allaire, Kenneth W. Kinzler, Ian G. Jennings, Philip E. Thompson, Philip A. Cole, L. Mario Amzel, Bert Vogelstein, Sandra B. Gabelli

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

    From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression Tekijä Oleg Schmidt‐Kittler, Thomas Ragg, Angela Daskalakis, Martin Granzow, A. Ahr, Thomas Blankenstein, Manfred Kaufmann, Joachim Diebold, H Arnholdt, Peter E. Müller, Joachim Bischoff, Detlev Harich, Günter Schlimok, Gert Riethmüller, Roland Eils, Christoph A. Klein

    Julkaistu 2003
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain

    Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain Tekijä Susanne Grünewald, Lillian R. Klug, Thomas Mühlenberg, Jonas Lategahn, Johanna Falkenhorst, Ajia Town, Christiane Ehrt, Eva Wardelmann, Wolfgang Hartmann, Hans‐Ulrich Schildhaus, Juergen Treckmann, Jonathan A. Fletcher, Sascha Jung, Paul Czodrowski, Steven P. Miller, Oleg Schmidt-Kittler, Daniel Rauh, Michael C. Heinrich, Sebastian Bauer

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

    Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial Tekijä Daniel J. DeAngelo, Deepti Radia, Tracy I. George, William A. Robinson, Albert Quiery, Mark W. Drummond, Prithviraj Bose, Elizabeth O. Hexner, Elliott F. Winton, Hans‐Peter Horny, Meera Tugnait, Oleg Schmidt-Kittler, Erica Evans, Huimin Lin, Brenton G. Mar, Srđan Verstovšek, Michael W. Deininger, Jason Gotlib

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations

    A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations Tekijä Erica Evans, Alexandra K. Gardino, Joseph L. Kim, Brian L. Hodous, Adam Shutes, Alison Davis, Xing Julia Zhu, Oleg Schmidt-Kittler, Doug Wilson, Kevin Wilson, Lucian DiPietro, Yulian Zhang, Natasja Brooijmans, Timothy P. LaBranche, Agnieszka Woźniak, Yemarshet K. Gebreyohannes, Patrick Schöffski, Michael C. Heinrich, Daniel J. DeAngelo, Steven P. Miller, Beni B. Wolf, Nancy E. Kohl, Timothy J. Guzi, NICHOLAS B. LYDON, Andy Boral, Christoph Lengauer

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across<i>FGFR2</i>Alterations and Resistance Mutations

    RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across<i>FGFR2</i>Alterations and Resistance Mutations Tekijä Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, Kamil Bruderek, B. Barry Touré, Songping Zhao, Roberto Valverde, Patrick J. O’Hearn, Demetri T. Moustakas, Heike Schönherr, Nastaran Gerami-Moayed, Alexander M. Taylor, Brandi M. Hudson, Damian J. Houde, Debjani Pal, Lindsey Foster, Hakan Günaydin, Pelin Ayaz, Dina A. Sharon, Lipika Goyal, Alison M. Schram, Suneel Kamath, Cori Ann Sherwin, Oleg Schmidt‐Kittler, Kai Yu Jen, Fabien Ricard, Beni B. Wolf, David E. Shaw, Donald A. Bergstrom, James Watters, Jessica B. Casaletto

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

    First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma Tekijä Richard D. Kim, Debashis Sarker, Tim Meyer, Thomas Yau, Teresa Macarulla, Joong‐Won Park, Su Pin Choo, Antoine Hollebecque, Max W. Sung, Ho-Yeong Lim, Vincenzo Mazzaferro, Joerg Trojan, Andrew X. Zhu, Jung‐Hwan Yoon, Sunil Sharma, Zhong-Zhe Lin, Stephen L. Chan, Sandrine Faivre, Lynn G. Feun, Chia-Jui Yen, Jean‐François Dufour, Daniel H. Palmer, Josep M. Llovet, Melissa Manoogian, Meera Tugnait, Nicolas Stransky, Margit Hagel, Nancy E. Kohl, Christoph Lengauer, Cori Ann Sherwin, Oleg Schmidt‐Kittler, Klaus P. Hoeflich, Hongliang Shi, Beni B. Wolf, Yoon‐Koo Kang

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: